Literature DB >> 19030431

A Canadian perspective on the American Academy of Pediatrics guidelines for acute otitis media.

Marina Salvadori1, Fatima Kakkar, Janice Sumpton.   

Abstract

Entities:  

Year:  2007        PMID： 19030431      PMCID： PMC2528786     

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN： 1205-7088            Impact factor:   2.253


× No keyword cloud information.
  12 in total

1.  Cefprozil concentrations in middle ear fluid of children with acute otitis media.

Authors:  M Trujillo; N Correa; K Olsen; H Trujillo; T Realpe; G I Mejia; J Robledo; G H McCracken
Journal:  Pediatr Infect Dis J       Date:  2000-03       Impact factor: 2.129

Review 2.  Otitis media: re-evaluation of diagnosis and treatment in the era of antimicrobial resistance, pneumococcal conjugate vaccine, and evolving morbidity.

Authors:  Stephen I Pelton
Journal:  Pediatr Clin North Am       Date:  2005-06       Impact factor: 3.278

3.  Cefprozil versus high-dose amoxicillin/clavulanate in children with acute otitis media.

Authors:  J A Hedrick; L D Sher; R H Schwartz; P Pierce
Journal:  Clin Ther       Date:  2001-02       Impact factor: 3.393

4.  Comparative safety and efficacy of cefdinir vs amoxicillin/clavulanate for treatment of suppurative acute otitis media in children.

Authors:  S L Block; J M McCarty; J A Hedrick; M A Nemeth; C H Keyserling; K J Tack
Journal:  Pediatr Infect Dis J       Date:  2000-12       Impact factor: 2.129

5.  Comparison of the palatability of the oral suspension of cefdinir vs. amoxicillin/clavulanate potassium, cefprozil and azithromycin in pediatric patients.

Authors:  J L Powers; W M Gooch; L P Oddo
Journal:  Pediatr Infect Dis J       Date:  2000-12       Impact factor: 2.129

6.  Empiric first-line antibiotic treatment of acute otitis in the era of the heptavalent pneumococcal conjugate vaccine.

Authors:  Jane Garbutt; Isabel Rosenbloom; Jenny Wu; Gregory A Storch
Journal:  Pediatrics       Date:  2006-06       Impact factor: 7.124

7.  Compliance issues related to the selection of antibiotic suspensions for children.

Authors:  R W Steele; M P Thomas; R E Bégué
Journal:  Pediatr Infect Dis J       Date:  2001-01       Impact factor: 2.129

8.  Effectiveness of five days of therapy with cefuroxime axetil suspension for treatment of acute otitis media.

Authors:  W M Gooch; E Blair; A Puopolo; R Z Paster; R H Schwartz; H C Miller; H L Smyre; R Yetman; G G Giguere; J J Collins
Journal:  Pediatr Infect Dis J       Date:  1996-02       Impact factor: 2.129

Review 9.  Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group.

Authors:  S F Dowell; J C Butler; G S Giebink; M R Jacobs; D Jernigan; D M Musher; A Rakowsky; B Schwartz
Journal:  Pediatr Infect Dis J       Date:  1999-01       Impact factor: 2.129

10.  Changes in frequency and pathogens causing acute otitis media in 1995-2003.

Authors:  Janet R Casey; Michael E Pichichero
Journal:  Pediatr Infect Dis J       Date:  2004-09       Impact factor: 2.129
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.